HARSCO CORP (HSC) Fundamental Analysis & Valuation

NYSE:HSCUS4158641070

Current stock price

9.15 USD
+0.21 (+2.35%)
At close:
9.27 USD
+0.12 (+1.31%)
After Hours:

This HSC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. HSC Profitability Analysis

1.1 Basic Checks

  • HSC had positive earnings in the past year.
  • In the past year HSC had a positive cash flow from operations.
HSC Yearly Net Income VS EBIT VS OCF VS FCFHSC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 200M 400M

1.2 Ratios

  • HSC has negative profitability rations, so we won't be analyzing them here.
  • The Return On Invested Capital of HSC (2.84%) is comparable to the rest of the industry.
  • HSC had an Average Return On Invested Capital over the past 3 years of 2.47%. This is significantly below the industry average of 10.58%.
  • The 3 year average ROIC (2.47%) for HSC is below the current ROIC(2.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 2.84%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.47%
ROIC(5y)3.89%
HSC Yearly ROA, ROE, ROICHSC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 50 -50

1.3 Margins

  • HSC has a Operating Margin (4.29%) which is in line with its industry peers.
  • HSC's Operating Margin has declined in the last couple of years.
  • HSC has a worse Gross Margin (18.37%) than 64.10% of its industry peers.
  • HSC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.29%
PM (TTM) N/A
GM 18.37%
OM growth 3Y-19.83%
OM growth 5Y-16.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.41%
GM growth 5Y-5.58%
HSC Yearly Profit, Operating, Gross MarginsHSC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 20 30

3

2. HSC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HSC is destroying value.
  • HSC has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for HSC is higher compared to a year ago.
HSC Yearly Shares OutstandingHSC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
HSC Yearly Total Debt VS Total AssetsHSC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 1.84 indicates that HSC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HSC has a Altman-Z score of 1.84. This is comparable to the rest of the industry: HSC outperforms 46.15% of its industry peers.
  • The Debt to FCF ratio of HSC is 14.30, which is on the high side as it means it would take HSC, 14.30 years of fcf income to pay off all of its debts.
  • HSC has a Debt to FCF ratio of 14.30. This is in the better half of the industry: HSC outperforms 61.54% of its industry peers.
  • HSC has a Debt/Equity ratio of 2.36. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of HSC (2.36) is worse than 85.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.36
Debt/FCF 14.3
Altman-Z 1.84
ROIC/WACC0.41
WACC6.98%
HSC Yearly LT Debt VS Equity VS FCFHSC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500M 1B

2.3 Liquidity

  • HSC has a Current Ratio of 1.28. This is a normal value and indicates that HSC is financially healthy and should not expect problems in meeting its short term obligations.
  • HSC has a Current ratio (1.28) which is comparable to the rest of the industry.
  • HSC has a Quick Ratio of 1.15. This is a normal value and indicates that HSC is financially healthy and should not expect problems in meeting its short term obligations.
  • HSC has a Quick ratio of 1.15. This is comparable to the rest of the industry: HSC outperforms 47.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.15
HSC Yearly Current Assets VS Current LiabilitesHSC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

4

3. HSC Growth Analysis

3.1 Past

  • HSC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.55%.
  • The earnings per share for HSC have been decreasing by -31.51% on average. This is quite bad
  • Looking at the last year, HSC shows a very strong growth in Revenue. The Revenue has grown by 20.95%.
  • Measured over the past years, HSC shows a small growth in Revenue. The Revenue has been growing by 7.64% on average per year.
EPS 1Y (TTM)-98.55%
EPS 3Y-54.13%
EPS 5Y-31.51%
EPS Q2Q%-1000%
Revenue 1Y (TTM)20.95%
Revenue growth 3Y7.9%
Revenue growth 5Y7.64%
Sales Q2Q%9.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 47.57% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 4.59% on average over the next years.
EPS Next Y-429.63%
EPS Next 2Y30.33%
EPS Next 3Y47.57%
EPS Next 5YN/A
Revenue Next Year2.58%
Revenue Next 2Y3.39%
Revenue Next 3Y3.57%
Revenue Next 5Y4.59%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HSC Yearly Revenue VS EstimatesHSC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
HSC Yearly EPS VS EstimatesHSC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1

3

4. HSC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 915.00, the valuation of HSC can be described as expensive.
  • HSC's Price/Earnings ratio is a bit more expensive when compared to the industry. HSC is more expensive than 64.10% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.71. HSC is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 48.97, the valuation of HSC can be described as expensive.
  • HSC's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of HSC to the average of the S&P500 Index (23.83), we can say HSC is valued expensively.
Industry RankSector Rank
PE 915
Fwd PE 48.97
HSC Price Earnings VS Forward Price EarningsHSC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800

4.2 Price Multiples

  • HSC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSC is cheaper than 75.64% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSC indicates a rather cheap valuation: HSC is cheaper than 92.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA 8.14
HSC Per share dataHSC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HSC's earnings are expected to grow with 47.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.33%
EPS Next 3Y47.57%

0

5. HSC Dividend Analysis

5.1 Amount

  • HSC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HSC Fundamentals: All Metrics, Ratios and Statistics

HARSCO CORP

NYSE:HSC (6/16/2023, 8:04:00 PM)

After market: 9.27 +0.12 (+1.31%)

9.15

+0.21 (+2.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-03
Earnings (Next)07-31
Inst Owners81.44%
Inst Owner Change0.22%
Ins Owners0.37%
Ins Owner Change0%
Market Cap729.61M
Revenue(TTM)1.93B
Net Income(TTM)-149.75M
Analysts77.5
Price Target13.26 (44.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)88.56%
Min EPS beat(2)62.44%
Max EPS beat(2)114.67%
EPS beat(4)4
Avg EPS beat(4)155.96%
Min EPS beat(4)62.44%
Max EPS beat(4)269.74%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.21%
Min Revenue beat(2)0.79%
Max Revenue beat(2)7.64%
Revenue beat(4)4
Avg Revenue beat(4)3.05%
Min Revenue beat(4)0.79%
Max Revenue beat(4)7.64%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-347.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 915
Fwd PE 48.97
P/S 0.38
P/FCF 7.66
P/OCF 3.29
P/B 1.28
P/tB N/A
EV/EBITDA 8.14
EPS(TTM)0.01
EY0.11%
EPS(NY)0.19
Fwd EY2.04%
FCF(TTM)1.19
FCFY13.05%
OCF(TTM)2.78
OCFY30.39%
SpS24.23
BVpS7.14
TBVpS-6.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 2.84%
ROICexc 2.96%
ROICexgc 6.22%
OM 4.29%
PM (TTM) N/A
GM 18.37%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.47%
ROIC(5y)3.89%
ROICexc(3y)2.56%
ROICexc(5y)4.05%
ROICexgc(3y)5.6%
ROICexgc(5y)8.1%
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-19.54%
ROICexgc growth 5Y-18.65%
ROICexc growth 3Y-17.35%
ROICexc growth 5Y-21.85%
OM growth 3Y-19.83%
OM growth 5Y-16.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.41%
GM growth 5Y-5.58%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 2.36
Debt/FCF 14.3
Debt/EBITDA 5.55
Cap/Depr 77.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.15
Altman-Z 1.84
F-Score4
WACC6.98%
ROIC/WACC0.41
Cap/Depr(3y)84.83%
Cap/Depr(5y)97.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.55%
EPS 3Y-54.13%
EPS 5Y-31.51%
EPS Q2Q%-1000%
EPS Next Y-429.63%
EPS Next 2Y30.33%
EPS Next 3Y47.57%
EPS Next 5YN/A
Revenue 1Y (TTM)20.95%
Revenue growth 3Y7.9%
Revenue growth 5Y7.64%
Sales Q2Q%9.46%
Revenue Next Year2.58%
Revenue Next 2Y3.39%
Revenue Next 3Y3.57%
Revenue Next 5Y4.59%
EBIT growth 1Y50.18%
EBIT growth 3Y-13.49%
EBIT growth 5Y-10.08%
EBIT Next Year290.02%
EBIT Next 3Y65.64%
EBIT Next 5YN/A
FCF growth 1Y222.26%
FCF growth 3YN/A
FCF growth 5Y-30.03%
OCF growth 1Y426.73%
OCF growth 3YN/A
OCF growth 5Y-3.18%

HARSCO CORP / HSC Fundamental Analysis FAQ

What is the fundamental rating for HSC stock?

ChartMill assigns a fundamental rating of 3 / 10 to HSC.


What is the valuation status of HARSCO CORP (HSC) stock?

ChartMill assigns a valuation rating of 2 / 10 to HARSCO CORP (HSC). This can be considered as Overvalued.


Can you provide the profitability details for HARSCO CORP?

HARSCO CORP (HSC) has a profitability rating of 1 / 10.


What is the financial health of HARSCO CORP (HSC) stock?

The financial health rating of HARSCO CORP (HSC) is 4 / 10.


What is the expected EPS growth for HARSCO CORP (HSC) stock?

The Earnings per Share (EPS) of HARSCO CORP (HSC) is expected to decline by -429.63% in the next year.